Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (18675)	4/6/1998 8:30:00 AM
From: Proton	Respond to of 32384

Re: Olympics & Other Matters [Mostly On Topic] Is the standing ad hominem attack a winter or summer event? ;-) LOL... I suppose it depends on how thin the ice is where the participant is standing. :-) Wishing that Wall Street promptly recognize this as very good news - I disagree. Oh, hey, c'mon... a guy can "hope," can't he? ;-) I don't think I implied that I need prompt Wall Street recognition. I suggested a possible way to jump start same. This subthread emanated from my interest in determining the impact of the tamoxifen study on LGND. Biotech stocks tend to get ill quite quickly when faced with success from competitors (that happens when you have no earnings). For this reason, I will be content to wait for Wall Street's recognition as long as necessary (as I slowly increase my position, all the while.) How efficient we wish the market to be depends on whether we have finished accumulating our positions. :-) Pý